Collagen Mimetic Peptide Mediated Delivery of DNA Carriers for Efficient Delivery from Collagen

Technology

Researchers at the University of Delaware have devised an innovative and novel method of amplifying the magnitude and duration of transgene expression. This method uses the collagen mimetic peptide (CMP) mediated delivery of non-viral DNA from collagen containing scaffolds. The composition of the polyplex used is variable, allowing customized release of the contents. CMP – modification has proven to increase the transgene expression for 10 fold longer duration. The CMP-polyplex-collagen complex augments the collagen activity in in vitro wound models and increase platelet derived growth factor BB expression for enhanced wound closure rates. These properties make the scaffolds a promising tool in regenerative healing.

Benefits

  • 10 fold increase in the duration of transgene expression, as seen in mice model
  • Commercial applications in wound repair, immunogenic and oncogenic distresses
  • Customizable retention/release of the cargo
  • Effective and stable incorporation with no off-target side-effects
  • Efficient delivery of small biomolecules as well as growth factors
  • Localized cell triggered delivery
  • Low dosage as compared to available collagen scaffolds